Cite
Rare disease research workflow using multilayer networks elucidates the molecular determinants of severity in Congenital Myasthenic Syndromes.
MLA
Núñez-Carpintero, Iker, et al. “Rare Disease Research Workflow Using Multilayer Networks Elucidates the Molecular Determinants of Severity in Congenital Myasthenic Syndromes.” Nature Communications, vol. 15, no. 1, Feb. 2024, p. 1227. EBSCOhost, https://doi.org/10.1038/s41467-024-45099-0.
APA
Núñez-Carpintero, I., Rigau, M., Bosio, M., O’Connor, E., Spendiff, S., Azuma, Y., Topf, A., Thompson, R., ’t Hoen, P. A. C., Chamova, T., Tournev, I., Guergueltcheva, V., Laurie, S., Beltran, S., Capella-Gutiérrez, S., Cirillo, D., Lochmüller, H., & Valencia, A. (2024). Rare disease research workflow using multilayer networks elucidates the molecular determinants of severity in Congenital Myasthenic Syndromes. Nature Communications, 15(1), 1227. https://doi.org/10.1038/s41467-024-45099-0
Chicago
Núñez-Carpintero, Iker, Maria Rigau, Mattia Bosio, Emily O’Connor, Sally Spendiff, Yoshiteru Azuma, Ana Topf, et al. 2024. “Rare Disease Research Workflow Using Multilayer Networks Elucidates the Molecular Determinants of Severity in Congenital Myasthenic Syndromes.” Nature Communications 15 (1): 1227. doi:10.1038/s41467-024-45099-0.